Sex: F
Vaccine: COVID19
Symptoms: Bedridden, Malaise, Rash papular, Scar, Shock
Clinical narrative: Two months laid in bed, did not know if she would live or not; Both arms were complete dark brown, and the skin felt like leather; Has open sores all over her arms; Permanent scaring; Big red  lumps that are elevated; Did not know if she would live or not; With in 40 minutes from received Moderna second vaccine , her body went to complete shock; This spontaneous case was reported by a patient and describes the occurrence of SHOCK (With in 40 minutes from received Moderna second vaccine , her body went to complete shock) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     Up to Moderna vaccination time patient was perfectly healthy person, full of energy, never had surgery, she was a volunteer for homeless shelter for 25 years, for 16 years she work to get shelter for homeless people.  Concurrent medical conditions included Food allergy (Patient was born to food allergies, severe food allergies.).    On 02-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced SHOCK (With in 40 minutes from received Moderna second vaccine , her body went to complete shock) (seriousness criterion medically significant). On an unknown date, the patient experienced BEDRIDDEN (Two months laid in bed, did not know if she would live or not), SKIN DISCOLOURATION (Both arms were complete dark brown, and the skin felt like leather), SKIN LESION (Has open sores all over her arms), SCAR (Permanent scaring), RASH PAPULAR (Big red  lumps that are elevated) and MALAISE (Did not know if she would live or not). At the time of the report, SHOCK (With in 40 minutes from received Moderna second vaccine , her body went to complete shock), BEDRIDDEN (Two months laid in bed, did not know if she would live or not), SKIN DISCOLOURATION (Both arms were complete dark brown, and the skin felt like leather), SKIN LESION (Has open sores all over her arms), SCAR (Permanent scaring), RASH PAPULAR (Big red  lumps that are elevated) and MALAISE (Did not know if she would live or not) had not resolved.            No concomitant drugs were reported.  It was reported that within 40 minutes from received Moderna second vaccine , her body went to complete shock, for two months laid in bed, did not know if she would live or not, both arms were complete dark brown, and the skin felt like leather. Now she has open sores all over her arms, permanent scaring, big red lumps that were elevated. She reported that if she wasn't as healthy as she was, patient would be died today.  No treatment medication were reported.  Company Comment: This spontaneous case reported by a patient concerns a female patient of unknown age, with no relevant medical history, who experienced unexpected, serious (medically significant) event shock after receiving a second dose of mRNA-1273.  She reports that with in 40 minutes of vaccination, her body went to complete shock.  Thereafter, she spent around two months in bed.  Both her arms became brown with leather-like skin, open sores and big red elevated lumps.  Skin now has permanent scarring.  No diagnostic tests, concomitant medications, or treatment details reported.  The benefit risk relationship of mRNA-1273 is not affected by this report.; Sender's Comments: This spontaneous case reported by a patient concerns a female patient of unknown age, with no relevant medical history, who experienced unexpected, serious (medically significant) event shock after receiving a second dose of mRNA-1273.  She reports that with in 40 minutes of vaccination, her body went to complete shock.  Thereafter, she spent around two months in bed.  Both her arms became brown with leather-like skin, open sores and big red elevated lumps.  Skin now has permanent scarring.  No diagnostic tests, concomitant medications, or treatment details reported.  The benefit risk relationship of mRNA-1273 is not affected by this report.